uploads/2018/02/doctors-office-checkup-medical-2610509.jpg

Merit Medical Systems: Analysts’ Ratings in February 2018

By

Updated

Merit Medical Systems

Merit Medical Systems (MMSI) is engaged in designing, developing, manufacturing, and marketing single-use medical products for interventional, diagnostic, and therapeutic procedures. The company is a leading manufacturer and marketer of disposable medical devices.

Article continues below advertisement

Business strategy

Merit Medical Systems has a four-pronged business strategy in place. The strategy includes enhancing growth and profitability with a focus on research and development, optimizing the sales model, growing through strategic acquisitions, and cost discipline.

The company also focuses on designing lean processes, cost-effective environments, and asset utilization to optimize operational capability.

Merit Medical Systems seeks high growth and high return opportunities through innovation and acquisitions in its target product groups of peripheral, cardiac, interventional oncology, spine, and endoscopy.

Merit Medical Systems maintains a customer-focused enterprise that’s guided by strong core values.

Analysts’ recommendations

Of the eight analysts covering Merit Medical Systems in February 2018, four analysts gave the stock a “strong buy” rating, three analysts gave it a “buy” rating, and one analyst gave it a “sell” rating. The mean rating for the stock is 1.63 with a target price of $49.86.

Peers’ ratings

Of the ten analysts covering Abiomed (ABMD) in February 2018, eight analysts gave the stock a “buy” or a higher rating, while two analysts gave it a “hold” rating. The target price for the stock is $281.2.

Of the 22 analysts covering Edwards Lifesciences (EW) in February 2018, 17 analysts gave the stock a “buy” or a higher rating, while four analysts gave it a “hold” rating. The mean rating for the stock is two with a target price of $144.2.

Of the 12 analysts covering Teleflex (TFX) in February 2018, ten analysts gave the stock a “buy” or a higher rating, while two analysts gave it a “hold” rating. The mean rating for the stock is 1.75 with a target price of $288.3.

Next, we’ll discuss Merit Medical Systems’ business segments.

Advertisement

More From Market Realist